MannKind

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.38-$7.63
Market Cap
$1.2B
Shares Short
23M

Financials

See more
Revenue (12 Mos)
$301.7M
Revenue Growth (YoY)
5.7%
Gross Profit (12 Mos)
$226M
Diluted EPS
$0.11

News

See more

Yahoo Finance • 7 hours ago

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

Yahoo Finance • yesterday

MannKind stock price target raised to $8 by RBC on scPharmaceuticals deal

Yahoo Finance • 2 days ago

Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7

Yahoo Finance • 2 days ago

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

About

CEO
Dr. Michael E. Castagna Pharm.D.
Address
1 Casper Street, Danbury, CT, United States, 06810
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
403